Accuray Gross Margin 2010-2023 | ARAY
Current and historical gross margin for Accuray (ARAY) over the last 10 years. The current gross profit margin for Accuray as of December 31, 2023 is %.
| Accuray Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-12-31 | $0.45B | $0.15B | 34.00% |
| 2023-09-30 | $0.46B | $0.16B | 34.95% |
| 2023-06-30 | $0.45B | $0.16B | 34.68% |
| 2023-03-31 | $0.44B | $0.16B | 36.45% |
| 2022-12-31 | $0.42B | $0.16B | 37.41% |
| 2022-09-30 | $0.42B | $0.16B | 37.32% |
| 2022-06-30 | $0.43B | $0.16B | 37.53% |
| 2022-03-31 | $0.43B | $0.16B | 37.67% |
| 2021-12-31 | $0.44B | $0.17B | 38.22% |
| 2021-09-30 | $0.42B | $0.17B | 39.47% |
| 2021-06-30 | $0.40B | $0.16B | 40.40% |
| 2021-03-31 | $0.38B | $0.16B | 41.05% |
| 2020-12-31 | $0.38B | $0.16B | 41.11% |
| 2020-09-30 | $0.38B | $0.15B | 40.11% |
| 2020-06-30 | $0.38B | $0.15B | 39.06% |
| 2020-03-31 | $0.41B | $0.16B | 38.42% |
| 2019-12-31 | $0.41B | $0.16B | 38.39% |
| 2019-09-30 | $0.41B | $0.16B | 38.11% |
| 2019-06-30 | $0.42B | $0.16B | 38.76% |
| 2019-03-31 | $0.42B | $0.16B | 39.52% |
| 2018-12-31 | $0.41B | $0.16B | 38.83% |
| 2018-09-30 | $0.41B | $0.16B | 39.27% |
| 2018-06-30 | $0.41B | $0.16B | 39.75% |
| 2018-03-31 | $0.40B | $0.16B | 38.71% |
| 2017-12-31 | $0.40B | $0.16B | 38.75% |
| 2017-09-30 | $0.39B | $0.15B | 37.89% |
| 2017-06-30 | $0.38B | $0.14B | 36.46% |
| 2017-03-31 | $0.37B | $0.13B | 36.51% |
| 2016-12-31 | $0.38B | $0.14B | 38.40% |
| 2016-09-30 | $0.40B | $0.16B | 39.39% |
| 2016-06-30 | $0.40B | $0.16B | 39.85% |
| 2016-03-31 | $0.41B | $0.16B | 39.90% |
| 2015-12-31 | $0.40B | $0.16B | 39.10% |
| 2015-09-30 | $0.39B | $0.15B | 38.92% |
| 2015-06-30 | $0.38B | $0.15B | 38.16% |
| 2015-03-31 | $0.38B | $0.14B | 37.63% |
| 2014-12-31 | $0.38B | $0.14B | 37.99% |
| 2014-09-30 | $0.38B | $0.14B | 38.40% |
| 2014-06-30 | $0.37B | $0.14B | 38.38% |
| 2014-03-31 | $0.35B | $0.13B | 37.11% |
| 2013-12-31 | $0.33B | $0.11B | 33.94% |
| 2013-09-30 | $0.31B | $0.10B | 32.15% |
| 2013-06-30 | $0.32B | $0.10B | 30.91% |
| 2013-03-31 | $0.33B | $0.11B | 32.13% |
| 2012-12-31 | $0.36B | $0.12B | 33.79% |
| 2012-09-30 | $0.39B | $0.14B | 34.69% |
| 2012-06-30 | $0.41B | $0.14B | 33.25% |
| 2012-03-31 | $0.38B | $0.13B | 34.46% |
| 2011-12-31 | $0.34B | $0.12B | 36.61% |
| 2011-09-30 | $0.28B | $0.11B | 39.44% |
| 2011-06-30 | $0.22B | $0.11B | 47.75% |
| 2011-03-31 | $0.21B | $0.11B | 50.24% |
| 2010-12-31 | $0.21B | $0.10B | 50.00% |
| 2010-09-30 | $0.21B | $0.10B | 47.85% |
| 2010-06-30 | $0.22B | $0.10B | 46.85% |
| 2010-03-31 | $0.22B | $0.10B | 45.66% |
| 2009-12-31 | $0.23B | $0.11B | 46.05% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.215B | $0.448B |
| Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $209.324B | 25.46 |
| Intuitive Surgical (ISRG) | United States | $130.862B | 78.83 |
| Edwards Lifesciences (EW) | United States | $52.344B | 34.65 |
| DexCom (DXCM) | United States | $50.703B | 87.10 |
| IQVIA Holdings (IQV) | United States | $41.988B | 24.90 |
| IDEXX Laboratories (IDXX) | United States | $39.830B | 47.62 |
| Alcon (ALC) | Switzerland | $39.749B | 29.31 |
| STERIS (STE) | Ireland | $19.852B | 23.50 |
| Hologic (HOLX) | United States | $17.891B | 19.75 |
| Waters (WAT) | United States | $17.747B | 25.47 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.624B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.289B | 84.91 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.059B | 14.89 |
| Sysmex ADR (SSMXY) | Japan | $9.956B | 31.22 |
| Teleflex (TFX) | United States | $9.763B | 15.33 |
| Penumbra (PEN) | United States | $7.857B | 97.13 |
| Masimo (MASI) | United States | $7.107B | 39.86 |
| Globus Medical (GMED) | United States | $6.938B | 22.00 |
| Glaukos (GKOS) | United States | $4.966B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.908B | 24.98 |
| LivaNova (LIVN) | United Kingdom | $2.914B | 19.22 |
| TransMedics (TMDX) | United States | $2.830B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.660B | 18.25 |
| PROCEPT BioRobotics (PRCT) | United States | $2.609B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.368B | 20.03 |
| Integra LifeSciences Holdings (IART) | United States | $2.278B | 9.35 |
| Inari Medical (NARI) | United States | $2.198B | 379.30 |
| Tandem Diabetes Care (TNDM) | United States | $2.049B | 0.00 |
| RxSight (RXST) | United States | $1.936B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.765B | 0.00 |
| Veracyte (VCYT) | United States | $1.490B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.876B | 16.20 |
| OPKO Health (OPK) | United States | $0.857B | 0.00 |
| Artivion (AORT) | United States | $0.837B | 96.76 |
| Paragon 28 (FNA) | United States | $0.812B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.718B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.685B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.682B | 0.00 |
| SiBone (SIBN) | United States | $0.639B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.552B | 18.73 |
| IRadimed (IRMD) | United States | $0.536B | 31.15 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.489B | 0.00 |
| Nevro (NVRO) | United States | $0.450B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.418B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.378B | 0.00 |
| NeuroPace (NPCE) | United States | $0.368B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.348B | 11.72 |
| CVRx (CVRX) | United States | $0.317B | 0.00 |
| AxoGen (AXGN) | United States | $0.300B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.266B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.265B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.251B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.185B | 9.95 |
| 908 Devices (MASS) | United States | $0.184B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.178B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.170B | 0.00 |
| Inogen (INGN) | United States | $0.158B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.149B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.140B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Neuronetics (STIM) | United States | $0.112B | 0.00 |
| Envoy Medical (COCH) | United States | $0.099B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.097B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.086B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.070B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.065B | 0.00 |
| Hyperfine (HYPR) | United States | $0.061B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.057B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 113.00 |
| Vasomedical (VASO) | United States | $0.051B | 9.17 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| InspireMD (NSPR) | Israel | $0.045B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.042B | 0.00 |
| DarioHealth (DRIO) | United States | $0.039B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.037B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.036B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |